Cost effectiveness of pre-prescription pharmacogenetic testing for irinotecan

Dyfrig Hughes; Angela Jones; Emily A. Fargher; Simon Gollins; Nick Stuart; John Wagstaff; Timothay S. Maughan; Munir Pirmohamed

Cost effectiveness of pre-prescription pharmacogenetic testing for irinotecan

Dyfrig Hughes
, Angela Jones
, Emily A. Fargher
, Simon Gollins
, Nick Stuart
, John Wagstaff
, Timothay S. Maughan
, Munir Pirmohamed

North Wales Medical School

Bangor University
BCUHB
Singleton Hospital
Gray Institute for Radiation Oncology and Biology
University of Liverpool

Research output: Book/Report › Commissioned report

15 Downloads (Pure)

Original language	English
Commissioning body	National Institute for Social Care and Health Research
Publication status	Unpublished - 30 Nov 2012

Access to Document

NISCHR final report irinotecan pharmacogenetics(1)Final published version, 2 MB

Cost-Effectiveness Of Pre-Prescription
Hughes, D. (PI)
1/01/07 → 10/09/13
Project: Research

Cite this

@book{815c214ee65d48e9bb8ce9585e15984f,

title = "Cost effectiveness of pre-prescription pharmacogenetic testing for irinotecan",

author = "Dyfrig Hughes and Angela Jones and Fargher, \{Emily A.\} and Simon Gollins and Nick Stuart and John Wagstaff and Maughan, \{Timothay S.\} and Munir Pirmohamed",

year = "2012",

month = nov,

day = "30",

language = "English",

}

TY - BOOK

T1 - Cost effectiveness of pre-prescription pharmacogenetic testing for irinotecan

AU - Hughes, Dyfrig

AU - Jones, Angela

AU - Fargher, Emily A.

AU - Gollins, Simon

AU - Stuart, Nick

AU - Wagstaff, John

AU - Maughan, Timothay S.

AU - Pirmohamed, Munir

PY - 2012/11/30

Y1 - 2012/11/30

M3 - Commissioned report

BT - Cost effectiveness of pre-prescription pharmacogenetic testing for irinotecan

ER -

Cost effectiveness of pre-prescription pharmacogenetic testing for irinotecan

Access to Document

Projects

Cost-Effectiveness Of Pre-Prescription

Cite this